2016-2020 EU5 Molecular Diagnostic Analyzers and Reagents Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing-Supplier Shares, Country Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. This new 1,273-page comprehensive five-country report from VPGMarketResearch. com is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years.
The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years. The $4. 5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years. Table of Contents I. IntroductionII. Worldwide Technology and Market Overview A. DNA Sequencing B. DNA and RNA Probes Technology C. Detection Technologies D. Instrumentation Review E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip F. Pharmacogenomics G. Major ApplicationsIII. FranceIV. GermanyV. ItalyVI. SpainVII. U. K. VIII. Major Product Development OpportunitiesIX. Design Criteria for Decentralized Testing ProductsX. Alternative Market Penetration StrategiesXI. Potential Market Entry Barriers and RisksXII. Competitive AssessmentsXIII. Appendix Contains 1,273 pages and 139 tables
The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years. The $4. 5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years. Table of Contents I. IntroductionII. Worldwide Technology and Market Overview A. DNA Sequencing B. DNA and RNA Probes Technology C. Detection Technologies D. Instrumentation Review E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip F. Pharmacogenomics G. Major ApplicationsIII. FranceIV. GermanyV. ItalyVI. SpainVII. U. K. VIII. Major Product Development OpportunitiesIX. Design Criteria for Decentralized Testing ProductsX. Alternative Market Penetration StrategiesXI. Potential Market Entry Barriers and RisksXII. Competitive AssessmentsXIII. Appendix Contains 1,273 pages and 139 tables
I. INTRODUCTION
II. Worldwide Technology and Market Overview
A. DNA Sequencing
B. DNA and RNA Probes Technology
C. Detection Technologies
D. Instrumentation Review
E. Biochips: Genosensors, Microarrays, and Labs on the Chip
F. Pharmacogenomics
G. Major Applications
III. France
IV. Germany
V. Italy
VI. Spain
VII. U.K.
VIII. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
IX. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
XII. COMPETITIVE ASSESSMENTS
XIII. Appendix
II. Worldwide Technology and Market Overview
A. DNA Sequencing
B. DNA and RNA Probes Technology
C. Detection Technologies
D. Instrumentation Review
E. Biochips: Genosensors, Microarrays, and Labs on the Chip
F. Pharmacogenomics
G. Major Applications
III. France
IV. Germany
V. Italy
VI. Spain
VII. U.K.
VIII. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
IX. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
XII. COMPETITIVE ASSESSMENTS
XIII. Appendix
